|
Volumn 15, Issue 6, 2006, Pages 402-
|
Non-indicated Oral Anticoagulation in Left Ventricular Hypertrabeculation/Noncompaction May Jeopardize These Patients
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTICOAGULANT AGENT;
CYTOCHROME P450 2C9;
PHENPROCOUMON;
ARTIFICIAL HEART PACEMAKER;
BARTH SYNDROME;
CONSENSUS;
DEFIBRILLATOR;
DISEASE ASSOCIATION;
DISEASE SEVERITY;
DISORDERS OF MITOCHONDRIAL FUNCTIONS;
DRUG INDICATION;
DYSTROPHY;
ELECTROCARDIOGRAM;
EMBOLISM;
ENZYME DEFICIENCY;
FRIEDREICH ATAXIA;
GENE MUTATION;
GENETIC POLYMORPHISM;
GLYCOGEN STORAGE DISEASE TYPE 2;
HEART ATRIUM FIBRILLATION;
HEART DISEASE;
HEART LEFT VENTRICLE FAILURE;
HEART LEFT VENTRICLE HYPERTRABECULATION;
HEREDITARY MOTOR SENSORY NEUROPATHY;
HUMAN;
HYPERTROPHIC CARDIOMYOPATHY;
INTERNATIONAL NORMALIZED RATIO;
LETTER;
MYOTONIC DYSTROPHY;
NEUROMUSCULAR DISEASE;
NUTRITION;
PREVALENCE;
PRIORITY JOURNAL;
RISK ASSESSMENT;
STROKE;
SYNCOPE;
ANTICOAGULANTS;
HEART VENTRICLES;
HUMANS;
VENTRICULAR DYSFUNCTION, LEFT;
|
EID: 33751421730
PISSN: 14439506
EISSN: None
Source Type: Journal
DOI: 10.1016/j.hlc.2006.07.001 Document Type: Letter |
Times cited : (1)
|
References (5)
|